| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active surveillance is superior to radical nephrectomy and equivalent to partial nephrectomy for preserving renal function in patients with small renal masses: Results from the DISSRM registry
|
Danzig, MR
|
|
2017
|
35 |
3 |
p. 116-
1 p.
|
artikel
|
| 2 |
Alcohol consumption and the risk of renal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Wozniak MB, Brennan P, Brenner DR, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Katzke V, Kühn T, Boeing H, Bergmann MM, Steffen A, Naska A, Trichopoulou A, Trichopoulos D, Saieva C, Grioni S, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Hjartåker A, Weiderpass E, Arriola L, Molina-Montes E, Duell EJ, Santiuste C, Alonso de la Torre R, Barricarte Gurrea A, Stocks T, Johansson M, Ljungberg B, Wareham N, Khaw KT, Travis RC, Cross AJ, Murphy N, Riboli E, Scelo G.Int J Cancer. 2015 Oct 15;137(8):1953-66. [Epub 2015 Apr 28]. doi: 10.1002/ijc.29559.
|
Jay, Raman
|
|
2017
|
35 |
3 |
p. 117-
1 p.
|
artikel
|
| 3 |
Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer. Lin CC, Gray PJ, Jemal A, Efstathiou JA, Surveillance and Health Services Research Program, Intramural Research, American Cancer Society, Atlanta, GA (CCL, AJ); Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (PJG, JAE); e-mail: jefstathiou@partners.org. J Natl Cancer Inst. 2015 May 9;107(7). pii: djv119. [Print 2015 Jul]. doi: 10.1093/jnci/djv119.
|
Scott, Eggener
|
|
2017
|
35 |
3 |
p. 122-123
2 p.
|
artikel
|
| 4 |
Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men
|
Granados, Jesús Benítez
|
|
2017
|
35 |
3 |
p. 111.e9-111.e14
1.1099889E16 p.
|
artikel
|
| 5 |
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Department of Medicine; Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; Johns Hopkins University, Baltimore; University of Wisconsin Carbone Cancer Center; School of Medicine and Public Health; Madison; Fox Chase Cancer Center, Temple University Health System, Philadelphia; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis; Mayo Clinic, Rochester, MN; University Hospitals Case Medical Center, Seidman Cancer Center; Cleveland Clinic Taussig Cancer Institute; Both in Cleveland; University of Virginia Cancer Center, Charlottesville; Comprehensive Cancer Centers of Nevada, Las Vegas; Siteman Cancer Center, Washington University School of Medicine, St. Louis; NorthShore University Health System, Evanston, IL; University of Michigan Comprehensive Cancer Center, Ann Arbor; Rutgers Cancer Institute of New Jersey, New Brunswick.N Engl J Med. 2015 Aug 20;373(8):737-46. [Epub 2015 Aug 5]. doi: 10.1056/NEJMoa1503747.
|
Scott, Eggener
|
|
2017
|
35 |
3 |
p. 123-
1 p.
|
artikel
|
| 6 |
Compensatory structural and functional adaptation after radical nephrectomy for renal cell carcinoma according to preoperative stage of chronic kidney disease. Choi DK, Jung SB, Park BH, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.J Urol. 2015 Oct;194(4):910-5. [Epub 2015 Apr 28]. doi: 10.1016/j.juro.2015.04.093.
|
Jay, Raman
|
|
2017
|
35 |
3 |
p. 118-119
2 p.
|
artikel
|
| 7 |
Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer
|
Sidana, Abhinav
|
|
2017
|
35 |
3 |
p. 114.e9-114.e14
1.1399886E16 p.
|
artikel
|
| 8 |
Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer
|
Zhang, Xiang
|
|
2017
|
35 |
3 |
p. 111.e15-111.e23
1.1099999889E25 p.
|
artikel
|
| 9 |
Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapies
|
Wark, Landon
|
|
2017
|
35 |
3 |
p. 112.e1-112.e11
1.1199999998881E13 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2017
|
35 |
3 |
p. i-
1 p.
|
artikel
|
| 11 |
Erratum to “The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System” [Urol Oncol 34(11) (2016) 486.e1–486.e7]
|
Mason, Ross
|
|
2017
|
35 |
3 |
p. 124-
1 p.
|
artikel
|
| 12 |
Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis 1 1 This study was supported by Grant from SAF-MINECO (ref: 2015-62215-R), Fundación Leticia Castillejo, Fundación para la Investigación en Urología of Asociación Española de Urología, Spain (AEU) (2011), Fundación para la Investigación Sanitaria (FIS) (ref: PI080432). The work carried out in our laboratory received support from the European Community through the regional development funding program (FEDER).
|
Serrano-Oviedo, Leticia
|
|
2017
|
35 |
3 |
p. 114.e15-114.e22
1.139999886E24 p.
|
artikel
|
| 13 |
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764.
|
Scott, Eggener
|
|
2017
|
35 |
3 |
p. 121-122
2 p.
|
artikel
|
| 14 |
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists
|
Lu, Diane D.
|
|
2017
|
35 |
3 |
p. 113.e1-113.e7
1.129998871E9 p.
|
artikel
|
| 15 |
Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade
|
Packiam, Vignesh T.
|
|
2017
|
35 |
3 |
p. 112.e19-112.e25
1.11999888E27 p.
|
artikel
|
| 16 |
Masthead
|
|
|
2017
|
35 |
3 |
p. IFC-
1 p.
|
artikel
|
| 17 |
Multi-quadrant biopsy technique improves diagnostic ability in large heterogeneous renal masses. Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.J Urol. 2015 Oct;194(4):886-91. [Epub 2015 Mar 30]. doi: 10.1016/j.juro.2015.03.106.
|
Jay, Raman
|
|
2017
|
35 |
3 |
p. 119-
1 p.
|
artikel
|
| 18 |
National treatment trends among older patients with T1-localized renal cell carcinoma 1 1 Dr. Simon P. Kim is supported by a career development award from the Conquer Cancer Foundation from the American Society of Clinical Oncology.
|
Kim, Simon P.
|
|
2017
|
35 |
3 |
p. 113.e15-113.e21
1.12999887E23 p.
|
artikel
|
| 19 |
Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate–dependent protein kinase and prostate cancer aggressiveness
|
Moen, Line Victoria
|
|
2017
|
35 |
3 |
p. 111.e1-111.e8
1.1099998891E10 p.
|
artikel
|
| 20 |
Percutaneous biopsy in large, locally advanced or metastatic renal tumors
|
Wittmann, Tyler A.
|
|
2017
|
35 |
3 |
p. 87-91
5 p.
|
artikel
|
| 21 |
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503.
|
Jay, Raman
|
|
2017
|
35 |
3 |
p. 117-118
2 p.
|
artikel
|
| 22 |
Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer
|
Soria, Francesco
|
|
2017
|
35 |
3 |
p. 113.e9-113.e14
1.1299887E16 p.
|
artikel
|
| 23 |
Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7.
|
Scott, Eggener
|
|
2017
|
35 |
3 |
p. 120-
1 p.
|
artikel
|
| 24 |
Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer
|
Shukla, Kamla Kant
|
|
2017
|
35 |
3 |
p. 92-101
10 p.
|
artikel
|
| 25 |
Strategies to overcome therapeutic resistance in renal cell carcinoma
|
Siska, Peter J.
|
|
2017
|
35 |
3 |
p. 102-110
9 p.
|
artikel
|
| 26 |
Table of Contents
|
|
|
2017
|
35 |
3 |
p. ii-iii
nvt p.
|
artikel
|
| 27 |
The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer
|
Song, Wan
|
|
2017
|
35 |
3 |
p. 114.e1-114.e7
1.139998861E9 p.
|
artikel
|
| 28 |
The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy. Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Siddiqui MM, Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Sankineni S, Su D, Stamatakis L, Merino MJ, Choyke PL, Wood BJ, Pinto PA. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; e-mail: pintop@mail.nih.gov.J Urol. 2015 Jul;194(1):105-11. [Epub 2015 Jan 23]. doi: 10.1016/j.juro.2015.01.072.
|
Scott, Eggener
|
|
2017
|
35 |
3 |
p. 121-
1 p.
|
artikel
|
| 29 |
Urologic Oncology Survey Masthead
|
|
|
2017
|
35 |
3 |
p. 115-
1 p.
|
artikel
|
| 30 |
Vitamin K epoxide reductase expression and prostate cancer risk
|
Tew, Ben Yi
|
|
2017
|
35 |
3 |
p. 112.e13-112.e18
1.1199888E20 p.
|
artikel
|
|
Tijdschrift beschrijving